Emmanuel T. Nyama

Emmanuel T. Nyama

Auto-generated profile, based on publicly available information

Emmanuel T. Nyama

Partners In Health, Freetown, Sierra Leone, Britannica, WA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Clinical Liver Disease
Verified
Journal Article
Closed access
WLWilliams Lebbie
Williams Lebbie
LALao-Tzu Allan-Blitz
Lao-Tzu Allan-Blitz
ENEmmanuel T. Nyama
Emmanuel T. Nyama
MSMohamed Swaray
Mohamed Swaray
DLDaniel Lavalie
Daniel Lavalie
RBRemy Bitwayiki
Remy Bitwayiki
HBV disproportionately affects resource-limited settings, and retaining patients in longitudinal care remains challenging. We conducted a mixed methods investigation to understand the causes of losses to follow-up within an HBV clinic in rural Sierra Leone. We developed a multivariable logistic regression model of baseline clinical and sociodemographic factors predicting losses to follow-up, defined as failing to present for a follow-up visit within 14 months of enrollment. We included patients enrolled between April 30, 2019 and March 1, 2020, permitting 14 months of follow-up by April 30, 2021. We then developed a survey to solicit patient perspectives on the challenges surrounding retention. We interviewed randomly selected patients absent from HBV care for at least 6 months. Among 271 patients enrolled in the Kono HBV clinic, 176 (64.9%) did not have a follow-up visit within 14 months of the study end point. Incomplete baseline workup (aOR 2.9; 95% CI: 1.6–4.8), lack of treatment at baseline (aOR 5.0; 95% CI: 1.7–14.4), and having cirrhosis at baseline (aOR 3.3; 95% CI: 0.99–10.8) were independently associated with being lost to follow-up. For the patient survey, 21 patients completed the interview (median age 34 years [IQR: 25–38]). Travel-related factors were the most frequently reported barrier to retention (57%). Almost 30% suggested improved customer care might support retention in care; 24% requested to be given medication. In our setting, factors that might reduce losses to follow-up included expanded criteria for treatment initiation, overcoming transportation barriers, reducing wait times, ensuring against stockouts, and scaling up point-of-care testing services.